Skip to main content
. 2020 Jul 21;80(1):96–102. doi: 10.1136/annrheumdis-2020-217209

Figure 3.

Figure 3

β-coefficients for continuous outcomes for 12-month period post-TNFi/non-TNFi initiation. *Change in continuous outcomes is defined as the outcome value at 1-year follow-up minus the outcome value at baseline. CDAI, Clinical Disease Activity Index; EQ-5D, EuroQol-5 Dimension; HAQ; Health Assessment Questionnaire; TNFi, tumour necrosis factor inhibitor.